| Question |
Answer |
| Anaphylaxia | exaggerated, life-threatening hypersensitivity reaction to a previously encountered antigen |
| antibody | protective protein produced by B lymphocytes in response to the presence of a foreign substances called an antigen, which the immune system regards as harmful to the host |
| antigen | substance that is recognized as harmful to the host and stimulates the formation of antibodies in an immunocompetent individual |
| cellular immunity | acquired specific resistance, mediated by T cells, that produces reactive substances or directly exerts a cytotoxic effect on a cell that is identified as harmful |
| host | organism in or on which another, usually parasitic, organism is nourished and harbored |
| hummoral immunity | acquited specific resistance, mediated by B cells, that produces antibodies that bind to and dispose of antigens |
| immunocempetent | able to develop an immune response; abled to recognize antigens and respond to them |
| immunopathology | study of disease states associated with overreactivity or underreactivity of the immune response |
| opportunistic infection | infection occurring in a person with a weakend immune system and caused by a microorgansim that, under normarl conditions, would not bring about disease |
| palliative treatment | treatment that provides relief, but not a cure |
| serum | lipid portions of blood that remains after the removal of fibrinogen |
Buen Viaje lv.2 ch 8
